Clinical Trials Browser

Phase 1/2 × OTHER × Pyrimethamine × Clear all

NCT01066663 2023-02-22

Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 1/2 Completed

20 enrolled 9 charts

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell